Send this to a friend

CT Children's invests in Mass. biotech company

Connecticut Children’s Medical Center said it has invested in a Holliston, Mass.-based biotechnology company that’s developing bioengineered organ implants to treat cancers and other life-threatening conditions of the esophagus, bronchus and trachea.
Biostage Inc. announced the funding on Wednesday along with the closing of a private placement with a group of investors from China totaling about $4.1 million. Connecticut Children’s ...

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

Copyright 2017 New England Business Media